Neurochemical and behavioral effects of bupropion and mecamylamine in the presence of nicotine

Brain Research

Volumn 1117, Issue 1, 2006, Pages 18-24

  Vann, Robert E ^a   Rosecrans, John A ^a   James, John R ^a   Philibin, Scott D ^a   Robinson, Susan E ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Bupropion; Nicotine; Operant; Rat; Rubidium efflux

Indexed keywords

AMFEBUTAMONE; MECAMYLAMINE; NICOTINE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; RUBIDIUM 86;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; BRAIN REGION; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; CORPUS STRIATUM; DISSECTING ANEURYSM; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; EFFUSION; EVALUATION; FRONTAL CORTEX; HIPPOCAMPUS; IN VIVO STUDY; MALE; NEUROCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; REINFORCEMENT; SYNAPTOSOME; THALAMUS; TREATMENT RESPONSE;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; BRAIN CHEMISTRY; BUPROPION; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; MALE; MECAMYLAMINE; NICOTINE; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; PRESYNAPTIC TERMINALS; RATS; RATS, INBRED F344; RECEPTORS, NICOTINIC; REINFORCEMENT (PSYCHOLOGY); RUBIDIUM RADIOISOTOPES; TOBACCO USE DISORDER;

EID: 33750008197     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.07.110     Document Type: Article

References (30)

1. Ascher J.A., Cole J.O., Colin J.N., Feighner J.P., Ferris R.M., Fibiger H.C., Golden R.N., Martin P., Potter W.Z., Richelson E., et al. Bupropion: a review of its mechanism of antidepressant activity. J. Clin. Psychiatry 56 (1995) 395-401
2. Balfour D.J. The pharmacology underlying pharmacotherapy for tobacco dependence: a focus on bupropion. Int. J. Clin. Pract. 55 (2001) 53-57
3. Broadbent J., Michael E.K., Riddle E.E., and Apple J.B. Involvement of dopamine uptake in the discriminative stimulus effects of cocaine. Behav. Pharmacol. 2 (1991) 187-197
4. Di Chiara G. Role of dopamine in the behavioural actions of nicotine related to addiction. Eur. J. Pharmacol. 393 (2000) 295-314
5. Fryer J.D., and Lukas R.J. Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine. J. Pharmacol. Exp. Ther. 288 (1999) 88-92
6. Glick S.D., Visker K.E., and Maisonneuve I.M. An oral self-administration model of nicotine preference in rats: effects of mecamylamine. Psychopharmacology (Berl) 128 (1996) 426-431
7. Hendry J.S., and Rosecrans J.A. Effects of nicotine on conditioned and unconditioned behaviors in experimental animals. Pharmacol. Ther. 17 (1982) 431-454
8. Hirschhorn I.D., and Rosecrans J.A. Studies on the time course and the effect of cholinergic and adrenergic receptor blockers on the stimulus effect of nicotine. Psychopharmacologia 40 (1974) 109-120
9. Kumar R., Reavill C., and Stolerman I.P. Nicotine cue in rats: effects of central administration of ganglion-blocking drugs. Br. J. Pharmacol. 90 (1987) 239-246
10. Malin D.H., Lake J.R., Smith T.D., Khambati H.N., Meyers-Paal R.L., Montellano A.L., Jennings R.E., Erwin D.S., Presley S.E., and Perales B.A. Bupropion attenuates nicotine abstinence syndrome in the rat. Psychopharmacology (Berl) 184 (2006) 494-503
11. Marks M.J., Farnham D.A., Grady S.R., and Collins A.C. Nicotinic receptor function determined by stimulation of rubidium efflux from mouse brain synaptosomes. J. Pharmacol. Exp. Ther. 264 (1993) 542-552
12. Marks M.J., Grady S.R., and Collins A.C. Downregulation of nicotinic receptor function after chronic nicotine infusion. J. Pharmacol. Exp. Ther. 266 (1993) 1268-1276
13. Marks M.J., Robinson S.F., and Collins A.C. Nicotinic agonists differ in activation and desensitization of 86Rb+ efflux from mouse thalamic synaptosomes. J. Pharmacol. Exp. Ther. 277 (1996) 1383-1396
14. McClernon F.J., and Rose J.E. Mecamylamine moderates cue-induced emotional responses in smokers. Addict. Behav. 30 (2005) 741-753
15. Meltzer L.T., and Rosecrans J.A. Tolerance to the disruptive effects of arecoline on schedule-controlled behavior. Psychopharmacology (Berl) 77 (1982) 85-93
16. Munzar P., and Goldberg S.R. Dopaminergic involvement in the discriminative-stimulus effects of methamphetamine in rats. Psychopharmacology (Berl) 148 (2000) 209-216
17. Papke R.L., Sanberg P.R., and Shytle R.D. Analysis of mecamylamine stereoisomers on human nicotinic receptor subtypes. J. Pharmacol. Exp. Ther. 297 (2001) 646-656
18. Peck A.W., and Hamilton M. Psychopharmacology of bupropion in normal volunteers. J. Clin. Psychiatry 44 (1983) 202-205
19. Philibin S.D., Vann R.E., Varvel S.A., Covington III H.E., Rosecrans J.A., James J.R., and Robinson S.E. Differential behavioral responses to nicotine in Lewis and Fischer-344 rats. Pharmacol. Biochem. Behav. 80 (2005) 87-92
20. Richelson E. Pharmacology of antidepressants-Characteristics of the ideal drug. Mayo Clin. Proc. 69 (1994) 1069-1081
21. Robinson S.E., James J.R., Lapp L.N., Vann R.E., Gross D.F., Philibin S.D., and Rosecrans J.A. Evidence of cellular nicotinic receptor desensitization in rats exhibiting nicotine-induced acute tolerance. Psychopharmacology (Berl) 184 (2006) 306-313
22. Rose J.E., Sampson A., Levin E.D., and Henningfield J.E. Mecamylamine increases nicotine preference and attenuates nicotine discrimination. Pharmacol. Biochem. Behav. 32 (1989) 933-938
23. Rosecrans J.A. Nicotine as a discriminative stimulus: a neurobiobehavioral approach to studying central cholinergic mechanisms. J. Subst. Abuse 1 (1989) 287-300
24. Rosecrans J.A., Stimler C.A., Hendry J.S., and Meltzer L.T. Nicotine-induced tolerance and dependence in rats and mice: studies involving schedule-controlled behavior. Prog. Brain Res. 79 (1989) 239-248
25. Rush C.R., Kollins S.H., and Pazzaglia P.J. Discriminative-stimulus and participant-rated effects of methylphenidate, bupropion, and triazolam in d-amphetamine-trained humans. Exp. Clin. Psychopharmacol. 6 (1998) 32-44
26. Shoaib M., Zubaran C., and Stolerman I.P. Antagonism of stimulus properties of nicotine by dihydro-beta-erythroidine (DHbetaE) in rats. Psychopharmacology (Berl) 149 (2000) 140-146
27. Slemmer J.E., Martin B.R., and Damaj M.I. Bupropion is a nicotinic antagonist. J. Pharmacol. Exp. Ther. 295 (2000) 321-327
28. Vann R.E., James J.R., Rosecrans J.A., and Robinson S.E. Nicotinic receptor inactivation after acute and repeated in vivo nicotine exposures in rats. Brain Res. 1086 (2006) 98-103
29. Wiley J.L., Lavecchia K.L., Martin B.R., and Damaj M.I. Nicotine-like discriminative stimulus effects of bupropion in rats. Exp. Clin. Psychopharmacol. 10 (2002) 129-135
30. Young R., and Glennon R.A. Nicotine and bupropion share a similar discriminative stimulus effect. Eur. J. Pharmacol. 443 (2002) 113-118